Modification of BRCA1-associated breast cancer risk by HMMR overexpressionFrancesca Mateo, Miguel Ángel Pujana, Conxi Lázaro et al.|Nature Communications|2022Cited by 53
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Aslihan Ugun‐Klusek, Francesca Mateo et al.|EMBO Molecular Medicine|2021Cited by 21
Immune Cell Associations with Cancer RiskLuís Palomero, Miguel Ángel Pujana, Iván Galván‐Femenía et al.|iScience|2020Cited by 14
Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and TissueRoderic Espín, Miguel Ángel Pujana, Alexandra Baiges et al.|Molecular Cancer Research|2021Cited by 9
Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary functionXavier Farré, Miguel Ángel Pujana, Roderic Espín et al.|ERJ Open Research|2021Cited by 3